Diazabicyclic central nervous system active agents
申请人:——
公开号:US20020019388A1
公开(公告)日:2002-02-14
Compounds of formula I
1
pharmaceutical compositions of these compounds, and use of said compositions to control synaptic transmission in mammals.
式I1的化合物,这些化合物的药物组合物,以及利用这些组合物来控制哺乳动物的突触传递。
Carbocyclic side chain containing, N-substituted metalloprotease inhibitors
申请人:——
公开号:US20030144292A1
公开(公告)日:2003-07-31
The compounds have a structure according to the following Formula (I):
1
are effective in treating conditions characterized by excess activity of metalloprotease enzymes.
化合物的结构符合以下公式(I):1,对于表现出金属蛋白酶酶活性过剩的病症具有治疗效果。
DIAZABICYCLIC CENTRAL NERVOUS SYSTEM ACTIVE AGENTS
申请人:Schrimpf R. Michael
公开号:US20080097094A1
公开(公告)日:2008-04-24
Compounds of formula I
pharmaceutical compositions of these compounds, and use of said compositions to control synaptic transmission in mammals.
化合物I的配方药物组合物,以及使用该组合物来控制哺乳动物的突触传递。
3-Cyclohexene-1-glycine, an Isoleucine Antagonist
作者:Jerome Edelson、John D. Fissekis、Charles G. Skinner、William Shive
DOI:10.1021/ja01544a028
日期:1958.6
CARBOCYCLIC SIDE CHAIN CONTAINING, N-SUBSTITUTED METALLOPROTEASE INHIBITORS